Data / Drug companies / Aspirin and caffeine
Aspirin and caffeine: 10 companies and 15 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Aspirin and caffeine is listed in the FDA National Drug Code Directory by 10 companies, with 15 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are powder; tablet, and the newest product started marketing on February 17, 2025.
The request: Get every company that lists aspirin and caffeine in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 10
- Products
- 15
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Stanback, BC Arthritis, Quality Choice Pain Relief Powder, BC Cherry, Reese Headache Powders, Goodys Hangover, Bayer Headache, Dollar General Headache Powders
- openFDA record search
- api.fda.gov
Companies that list aspirin and caffeine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Medtech Products Inc. | 6 | powder | Over the counter monograph drugs | February 17, 2025 |
| Bayer HealthCare LLC. | 1 | tablet | Over the counter monograph drugs | April 28, 2021 |
| Chain Drug Marketing Association | 1 | powder | Over the counter monograph drugs | March 25, 2021 |
| Dolgencorp, Inc. (dollar General & Rexall) | 1 | powder | Over the counter monograph drugs | March 31, 2021 |
| Family Dollar (family Wellness) | 1 | powder | Over the counter monograph drugs | April 27, 2023 |
| Lil' Drug Store Products, Inc. | 1 | powder | Over the counter monograph drugs | March 1, 2014 |
| Reese Pharmaceutical Co | 1 | powder | Over the counter monograph drugs | July 22, 2020 |
| Valu Merchandisers Company | 1 | powder | Over the counter monograph drugs | June 17, 2022 |
| Walgreen Company | 1 | powder | Over the counter monograph drugs | March 25, 2021 |
| Walmart Inc. | 1 | powder | Over the counter monograph drugs | March 25, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 14 | 93.3% |
| Tablet | 1 | 6.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 15 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Central Nervous System Stimulant | 15 |
| Methylxanthine | 15 |
| Nonsteroidal Anti-inflammatory Drug | 15 |
| Platelet Aggregation Inhibitor | 15 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.